CS MEDICA A/S invites to a live-streamed Status Event on August 16 at 16:00 CEST
CS MEDICA A/S (“CS MEDICA” or the “Company”) announces today that the company invites investors, brokers, analysts, and media to a live-streamed Event with a subsequent question and answer session on August 16 at 16:00 CEST.
CS MEDICA will shortly present top-line status within clinical trials, sales & growth, product pipeline, the liquidity situation, and current Investment opportunities. The purpose of the event is to provide investors, analysts, and media with a better understanding of the current situation in CS MEDICA. The event will be held in English.
Agenda for the Event
- CEO Comments
- MDR Plan Science and clinical trials
– Product pipeline
– First mover advantages
- Marketing branding, status and growth
- Presentation of sales strategy and pipeline
- Investment and Funding
Questions can be asked prior to the event by sending an email to email@example.com or during the webcast via a chat function. The webcast will also be available on demand on CS-MEDICA’s corporate website after the event.
Date and time
August 16, 2022, from 16:00-17:30 p.m. CEST
Registration for event >>
Live Webcast link >>.
Introducing the speakers
For more information about CS MEDICA, please contact:
Gitte Lund Henriksen, CFO
Phone: + (45) 2774 2280
CS MEDICA A/S is a Danish medico cannabis company founded in 2011. CS MEDICA is committed to developing, manufacturing, and commercializing over-the-counter (OTC) medical device products containing cannabinoids. The Company runs its business through the two fully-owned subsidiaries, Galaxa Pharma A/S (distributor and representative of foreign manufacturers in the Nordic, registered medical device product distributor) and CanNordic A/S (Medical device developer and seller (BtB), registered medical device product manufacturer). CS MEDICA distributes products across the European borders and is headquartered in Copenhagen, Denmark.
The company is listed on Spotlight Stock Market in Stockholm (symbol: “CSMED”). For more information about CS MEDICA cs-medica.com.